Company profile for Intech Biopharm Ltd

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Intech, established in 2010 as a spin-off from Synmosa, has leveraged its expertise in inhalation products to carve out a successful niche in respiratory drug development. The company is now poised for global expansion, focusing particularly on pressurized metered dose inhalers (pMDIs), a highly competitive segment with substantial market potential. In 2016, the pMDI market exceeded 30 billion USD.Intech has introduced the inn...
Intech, established in 2010 as a spin-off from Synmosa, has leveraged its expertise in inhalation products to carve out a successful niche in respiratory drug development. The company is now poised for global expansion, focusing particularly on pressurized metered dose inhalers (pMDIs), a highly competitive segment with substantial market potential. In 2016, the pMDI market exceeded 30 billion USD.Intech has introduced the innovative iLEF (inhaled low ethanol formulation) platform, which has already launched two products, Duasma and Synvent.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Taiwan
Address
Address
3F., No.36, Ln. 358, Ruiguang Rd., Dist., Taipei City 114
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Intech testing new asthma inhaler with eye on US market
Intech testing new asthma inhaler with eye on US market

01 Nov 2021

// Kao Shih-ching TAIPEITIMES

https://www.taipeitimes.com/News/biz/archives/2021/11/02/2003767143

Kao Shih-ching TAIPEITIMES
01 Nov 2021

https://www.prnewswire.com/news-releases/intec-announces-30-million-private-placement-ahead-of-decoy-merger-301340865.html

PRNEWSWIRE
26 Jul 2021

https://www.prnewswire.com/news-releases/intec-pharma-to-present-at-jefferies-virtual-healthcare-conference-301066816.html

PRNEWSWIRE
28 May 2020

https://www.prnewswire.com/news-releases/intec-pharma-to-participate-at-three-investment-conferences-in-march-301010738.html

PR NEWSWIRE
25 Feb 2020

http://www.pmlive.com/pharma_news/intec_battered_as_novartis_ducks_out_of_accordion_collaboration_1319783

Phil Taylor PMLIVE
13 Dec 2019

https://endpts.com/battered-cash-hungry-intec-feels-the-burn-of-novartis-rejection/

ENDPTS
11 Dec 2019

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty